Mechanisms of Action of Dimethyl Fumarate in Relapsing MS
Withdrawn prior to enrolment
Phase of Trial: Phase IV
Latest Information Update: 23 Jul 2016
At a glance
- Drugs Dimethyl fumarate (Primary)
- Indications Multiple sclerosis
- Focus Pharmacodynamics
- 07 Jun 2017 Biomarkers information updated
- 19 Jul 2016 Status changed from recruiting to withdrawn prior to enrolment.
- 07 Apr 2016 Planned End Date changed from 1 Jan 2019 to 1 Apr 2019.